1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine has been researched along with dihydroergocristine monomesylate in 2 studies
Studies (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Trials (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Recent Studies (post-2010) (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Studies (dihydroergocristine monomesylate) | Trials (dihydroergocristine monomesylate) | Recent Studies (post-2010) (dihydroergocristine monomesylate) |
---|---|---|---|---|---|
9 | 0 | 2 | 13 | 0 | 4 |
Protein | Taxonomy | 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine (IC50) | dihydroergocristine monomesylate (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.239 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 3 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.002 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 3 | |
Beta-3 adrenergic receptor | Homo sapiens (human) | 3.308 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.0015 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0079 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0087 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0007 | |
D(1A) dopamine receptor | Homo sapiens (human) | 1.179 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0074 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.015 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.239 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0007 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 3 | |
Mu-type opioid receptor | Homo sapiens (human) | 0.85 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.0023 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0066 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.042 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
2 other study(ies) available for 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine and dihydroergocristine monomesylate
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |